Delivery Order SPE2DX22D0010-SPE2D823FDE35

Award Date 1/23/23
Potential Completion Date 1/24/23
Potential Value $5.9K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DX22D0010|SPE2D823FCF31, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $5,132.36 firm fixed-price delivery order is for the supply of 40mg oxymorphone hydrochloride extended-release tablets, with a completion date of January 3, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $5,417.79, is for the delivery of oxymorphone hydrochloride extended-release tablets with a completion date of February 4, 2025. The contract is a firm fixed-price Delivery Order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, valued at $6,672.25, is a firm fixed price delivery order for 4,564,082,819 units of Oxymorphone Hydrochloride Extended-Release Tablets 40mg. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,570.06 firm-fixed-price delivery order covers the supply of Oxymorphone HCL ER 20 mg tablets. The contract has an ultimate completion date of March 8, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company. The $6,729.58 Firm Fixed Price Delivery Order is for the supply of 30mg Oxymorphone Hydrochloride Extended Release Tablets, a prescription medication. The award is associated with Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract, valued at up to $6,419.39, is for the delivery of Oxymorphone Hydrochloride Extended Release tablets, a prescription medication, to the government. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025,...
This federal contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading pharmaceutical distribution company. The $4,183.84 firm fixed price delivery order is for the supply of 60 units of the prescription drug oxymorphone hydrochloride extended-release 5 mg tablets. This order supports the DLA Troop Support Medical program, which provides pharmaceuticals and medical supplies to military treatment facilities....
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,683.00 firm fixed-price delivery order is for the supply of 4566779797 - Oxymorphone HCL ER 20 MG Tablets in 60-count packages. The contract has a completion date of December 23, 2024. This award is associated with Amerisourcebergen's...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,630.20 firm fixed-price delivery order is for the supply of 4566815810 - Oxymorphone HCL ER Tabs 20mg, with a performance period running through January 2, 2025. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
This federal contract award, valued at $1,000.16, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of oxymorphone hydrochloride extended-release tablets, a pain management medication, with a completion date of November 27, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
  • SPE2DX22D0010
    Indefinite Delivery Contract
  • SPE2DX22D0010-SPE2D823FDE35
    Delivery Order

This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,938.49 firm fixed-price delivery order is for the supply of 40mg oxymorphone hydrochloride extended-release tablets, with a completion date of January 24, 2023. The contract is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

Generated 2/25/25, 9:47 AM